BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19138366)

  • 1. Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: a pilot study.
    van der Made F; Bloemers J; van Ham D; El Yassem W; Kleiverda G; Everaerd W; Olivier B; Tuiten A
    J Sex Med; 2009 Feb; 6(2):429-39. PubMed ID: 19138366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction.
    van der Made F; Bloemers J; Yassem WE; Kleiverda G; Everaerd W; van Ham D; Olivier B; Koppeschaar H; Tuiten A
    J Sex Med; 2009 Mar; 6(3):777-90. PubMed ID: 19207276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of testosterone and vardenafil increases female sexual functioning in sub-primed rats.
    Snoeren EM; Bovens A; Refsgaard LK; Westphal KG; Waldinger MD; Olivier B; Oosting RS
    J Sex Med; 2011 Apr; 8(4):989-1001. PubMed ID: 21235726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
    Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
    van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbits.
    Angulo J; Cuevas P; Cuevas B; Bischoff E; De Tejada IS
    J Sex Med; 2006 Nov; 3(6):988-995. PubMed ID: 17100931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
    Chivers ML; Rosen RC
    J Sex Med; 2010 Feb; 7(2 Pt 2):858-72. PubMed ID: 19929916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of sexual arousal in women under conditions of institutional and ambulatory laboratory circumstances: a comparative study.
    Bloemers J; Gerritsen J; Bults R; Koppeschaar H; Everaerd W; Olivier B; Tuiten A
    J Sex Med; 2010 Mar; 7(3):1160-76. PubMed ID: 20136709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated and chronic administration of Vardenafil or Sildenafil differentially affects emotional and socio-sexual behavior in mice.
    Dadomo H; Parmigiani S; Nicolini Y; Freschini S; Gioiosa L; Patrelli TS; Palanza P; Volpi R
    Behav Brain Res; 2013 Sep; 253():103-12. PubMed ID: 23850358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
    Bloemers J; van Rooij K; Poels S; Goldstein I; Everaerd W; Koppeschaar H; Chivers M; Gerritsen J; van Ham D; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):791-809. PubMed ID: 23130782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial.
    Goldstein I; Fisher WA; Sand M; Rosen RC; Mollen M; Brock G; Karlin G; Pommerville P; Bangerter K; Bandel TJ; Derogatis LR;
    J Sex Med; 2005 Nov; 2(6):819-32. PubMed ID: 16422806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunction.
    Hatzichristou D; Cuzin B; Martin-Morales A; Buvat J; Porst H; Laferriere N; Bandel TJ; Montorsi F;
    J Sex Med; 2005 Jan; 2(1):109-16. PubMed ID: 16422913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs.
    Angulo J; Cuevas P; Cuevas B; Bischoff E; Sáenz de Tejada I
    Int J Impot Res; 2003 Apr; 15(2):137-41. PubMed ID: 12789394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.
    Debruyne FM; Gittelman M; Sperling H; Börner M; Beneke M
    J Sex Med; 2011 Oct; 8(10):2912-23. PubMed ID: 21883954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pre-existing affect on the sexual responses of women with and without a history of childhood sexual abuse.
    Rellini AH; Elinson S; Janssen E; Meston CM
    Arch Sex Behav; 2012 Apr; 41(2):329-39. PubMed ID: 21667233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration and maintenance of erection with vardenafil: a time-from-dosing analysis.
    Valiquette L; Montorsi F; Hellstrom WJ; Giuliano F; Homering M; Taylor T; Eardley I;
    Can J Urol; 2005 Jun; 12(3):2687-98; discussion 2699. PubMed ID: 16011816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
    Sperling H; Debruyne F; Boermans A; Beneke M; Ulbrich E; Ewald S
    J Sex Med; 2010 Apr; 7(4 Pt 1):1497-507. PubMed ID: 20233275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the clinical efficacy of vardenafil correlate with its effect on the endothelial function of cavernosal arteries? A pilot study.
    Mazo EB; Gamidov SI; Iremashvili VV
    BJU Int; 2006 Nov; 98(5):1054-8. PubMed ID: 17034606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
    Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
    Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy or psychotherapy?: effective treatment for FSD related to unresolved childhood sexual abuse.
    Berman LA; Berman JR; Bruck D; Pawar RV; Goldstein I
    J Sex Marital Ther; 2001; 27(5):421-5. PubMed ID: 11554202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.